具有鼻息肉的慢性鼻炎不会影响鼻刺激测试和血清过敏原特异性免疫球蛋白E水平之间的关联
HyoungSun Yoon1, Il-Youp Kwak2, KyungSoo Kim1
1Department of Otorhinolaryngology-Head and Neck Surgery, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Journal of rhinology : official journal of the Korean Rhinologic Society
|December 12, 2024
概括
在本研究中,具有鼻息肉的慢性鼻鼻炎 (CRSwNP) 没有影响鼻刺激测试 (NPT) 的结果或与过敏测试结果的相关性. 需要进一步的研究来证实这些关于过敏原挑战的发现.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 呼吸系统医学 呼吸系统医学
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一种影响上呼吸道的常见疾病.
- 鼻刺激测试 (NPT) 用于评估鼻腔通道中的过敏反应.
- CRSwNP对NPT结果的影响及其与过敏诊断的相关性仍然不清楚.
研究的目的:
- 为了比较鼻刺激试验 (NPT) 的结果,在患有和没有患有鼻息肉性慢性鼻炎 (CRSwNP) 的患者中.
- 调查CRSwNP是否影响对鼻内过敏原挑战的反应.
- 在CRSwNP患者中分析NPT结果与过敏测试结果 (MAST) 之间的相关性.
主要方法:
- 医疗记录的回顾性审查,包括NPT,MAST和鼻计算机断层扫描.
- 基于鼻腔内镜和CT扫描发现的CRSwNP诊断.
- 对室内灰尘进行了NPT;MAST阳性是由特定的IgE水平定义的.
主要成果:
- 在CRSwNP和非CRSwNP组之间,在MAST阳性度,乙氨基细胞计数或乙氨基细胞酸蛋白水平上没有显著差异.
- CRSwNP没有显著改变对鼻内室内粉尘虫挑战的反应.
- 在NPT结果和MAST结果之间的相关性没有受到CRSwNP的存在的影响.
结论:
- CRSwNP的存在不会影响鼻刺激测试结果或它们与过敏测试结果的关联.
- 建议进一步进行大规模的纵向研究,以验证这些发现在过敏原诱导的鼻腔反应中.
相关概念视频
02:06Allergic Reactions
27.2K
Overview
27.2K
01:23Chronic Pharyngitis
1.1K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
350
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
350
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237